Stevia, a natural sweetener, may help lower blood sugar after meals and improve cholesterol levels in people with diabetes or who are overweight.
Claim Context
Stevioside is associated with improved postprandial glucose control and favorable lipid profile changes in adults with overweight or type 2 diabetes, as demonstrated in multiple randomized controlled trials.
“Several human studies have assessed this effect through single-meal evaluations... significant reductions in postprandial blood glucose levels were observed when steviol glycosides were incorporated into reduced-sugar/calorie meals... daily consumption of 20 mL stevia extract... significantly reduced cholesterol, triglyceride, and LDL-c levels, while increasing HDL-c.”
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether stevioside consistently improves glycemic and lipid outcomes across diverse populations.
A systematic review and meta-analysis of 15+ RCTs comparing stevioside (≥100 mg/day) vs. placebo or sugar in adults with prediabetes or T2DM, measuring HbA1c, postprandial glucose, LDL, HDL, and triglycerides over ≥12 weeks.
Whether stevioside directly improves insulin sensitivity and lipid metabolism in humans.
A double-blind RCT of 150 adults with T2DM, randomized to 200 mg/day stevioside or placebo for 6 months, measuring HOMA-IR, fasting insulin, lipid panels, and liver fat via MRI.
Whether habitual stevia use predicts lower incidence of type 2 diabetes or cardiovascular disease.
A prospective cohort of 10,000 adults with baseline stevia use assessed via dietary recall, followed for 10 years to track incident T2DM, MI, and stroke.
Whether individuals with better metabolic health have higher prior stevia intake.
A case-control study comparing 400 adults with well-controlled T2DM (HbA1c <7%) to 400 with poorly controlled T2DM (HbA1c >8%), using validated food frequency questionnaires to estimate stevia intake over 5 years.
A clinical recommendation for stevia use in diabetes management.
A consensus statement from ADA and EFSA reviewing all human data to recommend stevioside as a preferred LCS for glycemic control in diabetic populations.